Clinical Efficacy Study of Transurethral Thulium Laser Enucleation of the Prostate and Transurethral Bipolar Plasma Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia
Abstract
OBJECTIVE
This study aims to evaluate the clinical efficacy of transurethral thulium laser enucleation of the prostate (ThuLEP) and transurethral bipolar plasma resection of the prostate (B-TURP) in the treatment of male benign prostatic hyperplasia (BPH) through a retrospective study.
METHODS
We retrospectively collected the medical records of male patients with BPH who were admitted to our hospital from January 2020 to December 2023. Patients were divided into two groups on the basis of the surgical approach: The ThuLEP group (T group) and the B-TURP group (B group). We compared the operative time, haemoglobin drop, weight of the resected tissue, bladder irrigation time, catheterisation time and hospital stay. The International Prostate Symptom Score (IPSS) and the International Consultation on Incontinence Questionnaire-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) were collected from patients in both groups in the first and third months after surgery. Information on postoperative complications during hospitalisation and at three months in both groups of patients was collected.
RESULTS
A total of 110 patients with BPH were included in this study (T group n = 56; B group n = 54). No statistically significant differences in age, body mass index (BMI), prostate volume and other general medical history data were observed between the two groups (p > 0.05). Moreover, no statistically significant difference was found in postoperative tube placement time and length of…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.